SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001047469-09-007997
Filing Date
2009-08-26
Accepted
2009-08-26 17:12:51
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4/A a2193894zs-4a.htm S-4/A 1919928
2 EXHIBIT 8.1 a2194131zex-8_1.htm EX-8.1 16061
3 EXHIBIT 8.2 a2194131zex-8_2.htm EX-8.2 14713
4 EX-23.1 a2193480zex-23_1.htm EX-23.1 2771
5 EX-23.2 a2193480zex-23_2.htm EX-23.2 2864
6 EX-23.4 a2193480zex-23_4.htm EX-23.4 2871
7 EXHIBIT 99.3 a2194346zex-99_3.htm EX-99.3 69733
9 G156842KMI001.JPG g156842kmi001.jpg GRAPHIC 1248
10 G825671.JPG g825671.jpg GRAPHIC 12325
11 G347176.JPG g347176.jpg GRAPHIC 3908
12 filename12.htm CORRESP 29654
  Complete submission text file 0001047469-09-007997.txt   2084336
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-160257 | Film No.: 091036953
SIC: 2835 In Vitro & In Vivo Diagnostic Substances